Lexicon Pharma (LXRX) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.41 -0.82%
Financial Fact:
Collaborative research: 27.69M
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Collaborative research: 27.69M
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of $0.01, $0.10 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $28.86 million versus the consensus estimate of $6.49 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Active options: NVDA TSLA SPCX MU AAPL INTC CRWV
- Ross Stores (ROST) call put ratio 7.4 calls to 1 put with a focus on August 14 weekly 260 and June 280 calls
- Hyster-Yale Materials (HY) Declares $0.365 Quarterly Dividend; 4.2% Yield
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
